Simon Marcelis, Business line Director Particle Therapy at IBA Dosimetry, will demonstrate "How can you automatize your Daily QA" on Sunday, April 28th at 1:00 PM on IBA booth #3500.

Securing the investment in proton therapy
Following a record nine-month installation program by IBA, Proton Partners International has been treating patients with the Proteus®ONE* solution at Rutherford Cancer Centre in Newport, South Wales for a year.


John Pettingell, Chief Physicist & Head of Radiotherapy at the Rutherford Cancer Centre, will describe the Centre's first-year experience with proton therapy and the transition to proton therapy in the UK on Monday, April 29th, at 3:45 PM at our IBA's booth, #3500.


Partnering with key market leaders in radiation oncology for optimal healthcare solutions
Thanks to its long-lasting partnerships with Elekta, Philips Healthcare, and RaySearch, IBA is able to showcase multiple workflow solutions designed to integrate proton therapy in the clinic and further illustrate its open integration approach.


About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. IBA is the worldwide technology leader in the field of Proton Therapy, considered to be the most advanced form of radiation therapy available today. IBA's Proton Therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale Proton Therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry division which develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing approximately 1,500 people worldwide, IBA has installed systems across the world.

Back to HCB News

Rad Oncology Homepage